Theodore R Schroeder Nabriva Therapeutics PLC (NBRV) insider trading activity

Theodore R Schroeder is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 11,989 shares of NBRV, which is worth approximately $4,795. The most recent transaction as insider was on Jan 29, 2023, when has been sold 431 shares (Ordinary Shares) at a price of $1.5 per share, resulting in proceeds of $646. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K

0% 3M change

0% 12M change

Total Value Held $4,795

Theodore R Schroeder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2023	SELL Payment of exercise price or tax liability	$646 $1.5 p/Share	431 Reduced 3.47%	11,989 Ordinary Shares
Jan 06 2023	SELL Payment of exercise price or tax liability	$14 $1.3 p/Share	11 Reduced 0.09%	12,420 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$9 $1.89 p/Share	5 Reduced 0.04%	12,431 Ordinary Shares
Dec 06 2022	SELL Payment of exercise price or tax liability	$18 $2.02 p/Share	9 Reduced 0.07%	12,436 Ordinary Shares
Nov 30 2022	SELL Payment of exercise price or tax liability	$11 $2.25 p/Share	5 Reduced 0.04%	12,445 Ordinary Shares
Nov 06 2022	SELL Payment of exercise price or tax liability	$22 $2.24 p/Share	10 Reduced 0.08%	12,450 Ordinary Shares
Oct 31 2022	SELL Payment of exercise price or tax liability	$12 $2.54 p/Share	5 Reduced 0.04%	12,460 Ordinary Shares
Oct 06 2022	SELL Payment of exercise price or tax liability	$24 $2.72 p/Share	9 Reduced 0.07%	12,465 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$10 $2.08 p/Share	5 Reduced 0.04%	12,474 Ordinary Shares
Sep 06 2022	SELL Payment of exercise price or tax liability	$36 $0.16 p/Share	225 Reduced 0.07%	311,977 Ordinary Shares
Aug 31 2022	SELL Payment of exercise price or tax liability	$17 $0.16 p/Share	107 Reduced 0.03%	312,202 Ordinary Shares
Aug 06 2022	SELL Payment of exercise price or tax liability	$41 $0.18 p/Share	225 Reduced 0.07%	312,309 Ordinary Shares
Jul 31 2022	SELL Payment of exercise price or tax liability	$19 $0.18 p/Share	107 Reduced 0.03%	312,534 Ordinary Shares
Jul 06 2022	SELL Payment of exercise price or tax liability	$41 $0.18 p/Share	225 Reduced 0.07%	312,641 Ordinary Shares
Jun 30 2022	SELL Payment of exercise price or tax liability	$19 $0.18 p/Share	107 Reduced 0.03%	312,866 Ordinary Shares
Jun 06 2022	SELL Payment of exercise price or tax liability	$45 $0.2 p/Share	225 Reduced 0.07%	312,973 Ordinary Shares
May 31 2022	SELL Payment of exercise price or tax liability	$22 $0.21 p/Share	107 Reduced 0.03%	313,198 Ordinary Shares
May 06 2022	SELL Payment of exercise price or tax liability	$58 $0.26 p/Share	225 Reduced 0.07%	313,305 Ordinary Shares
Apr 30 2022	SELL Payment of exercise price or tax liability	$33 $0.31 p/Share	107 Reduced 0.03%	313,530 Ordinary Shares
Apr 06 2022	SELL Payment of exercise price or tax liability	$90 $0.41 p/Share	219 Reduced 0.07%	313,637 Ordinary Shares
Mar 31 2022	SELL Payment of exercise price or tax liability	$44 $0.42 p/Share	104 Reduced 0.03%	313,856 Ordinary Shares
Mar 06 2022	SELL Payment of exercise price or tax liability	$113 $0.43 p/Share	263 Reduced 0.08%	313,960 Ordinary Shares
Feb 28 2022	SELL Payment of exercise price or tax liability	$56 $0.45 p/Share	125 Reduced 0.04%	314,223 Ordinary Shares
Feb 06 2022	SELL Payment of exercise price or tax liability	$126 $0.48 p/Share	263 Reduced 0.08%	314,348 Ordinary Shares
Jan 31 2022	SELL Payment of exercise price or tax liability	$60 $0.48 p/Share	125 Reduced 0.04%	314,611 Ordinary Shares

Also insider at

OTIC

OTONOMY, INC. Healthcare

Director

CDTX

Cidara Therapeutics, Inc. Healthcare

Director

TRS